Anderson Hoagland & CO Eli Lilly & CO Transaction History

Anderson Hoagland & CO

$964 Million
Q3 2024

A detailed history of Anderson Hoagland & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Anderson Hoagland & CO holds 22,779 shares of LLY stock, worth $17.5 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares

22,779

Previous 22,806 0.12%

Holding current value

$17.5 Million

Previous $20.6 Million 2.27%

% of portfolio

2.09%

Previous 2.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$772.14 - $960.02 $20,847 - $25,920	-27 Reduced 0.12%	22,779 $20.2 Million
Q2 2024 Jul 10, 2024	SELL	$724.87 - $909.04 $12,322 - $15,453	-17 Reduced 0.07%	22,806 $20.6 Million
Q1 2024 Apr 11, 2024	BUY	$592.2 - $792.28 $153,972 - $205,992	260 Added 1.15%	22,823 $17.8 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $290,379 - $400,332	668 Added 3.05%	22,563 $12.1 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $126,426 - $148,481	407 Added 1.89%	21,895 $7.52 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $250,165 - $291,493	778 Added 3.76%	21,488 $0
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $568,945 - $648,372	1,919 Added 10.21%	20,710 $6.7 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $1.69 Million - $1.99 Million	6,073 Added 47.75%	18,791 $6.16 Million
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $26,754 - $33,249	-114 Reduced 0.89%	12,718 $3.64 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $36,650 - $45,483	163 Added 1.29%	12,832 $3.09 Million
Q3 2021 Oct 07, 2021	SELL	$221.6 - $272.71 $22,603 - $27,816	-102 Reduced 0.8%	12,669 $2.93 Million
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $28,165 - $36,432	156 Added 1.24%	12,771 $2.93 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $726,270 - $961,031	5,567 Added 78.99%	12,615 $2.13 Million
Q3 2020 Oct 06, 2020	BUY	$146.22 - $169.13 $1.03 Million - $1.19 Million	7,048 New	7,048 $1.06 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anderson Hoagland & CO, based on Form 13F filings with the SEC.

News

Stay updated on Anderson Hoagland & CO with notifications on news.

Account

Anderson Hoagland & CO Eli Lilly & CO Transaction History